The PSA test has relatively high false positive and false negative rates, prostate biopsies can miss cancers, and the highly variable nature of prostate cancer means there is potential for diagnosis of indolent cancers that may never present as a problem [6,7]. The gene discussed is KLK3; the disease is prostate carcinoma.